Larimar Therapeutics (LRMR)
Develops nomlabofusp to deliver frataxin in Friedreich's ataxia.
$3.74
vs last close−0.08 (−2.23%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$0.39
Revenue estimate
—
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.45−$0.46−$0.41−$0.61−$0.73−$0.31−$0.30Pending
Estimate−$0.29−$0.42−$0.47−$0.39−$0.44−$0.53−$0.38−$0.39
Surprise−55.2%−9.5%+12.8%−56.4%−65.9%+41.5%+21.4%—
RevenueReportedEstimate
Mar '25Apr '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$241.0K——————Pending
Estimate————————
Surprise————————
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.31 | — | — |
| Sep 2027 | −$0.39 | — | — |
| Jun 2027 | −$0.23 | — | — |
| Mar 2027 | −$0.41 | — | — |
| Dec 2026 | −$0.39 | — | — |
| Nov 2026 | −$0.39 | — | — |
| Aug 2026 | −$0.38 | −$0.30 | +21.4% |
| May 2026 | −$0.53 | −$0.31 | +41.5% |
| Mar 2026 | −$0.44 | −$0.73 | −65.9% |
| Nov 2025 | −$0.39 | −$0.61 | −56.4% |
| Aug 2025 | |||
| Apr 2025 | |||
| Mar 2025 | |||
| Oct 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.31 | — | — | $18.3M | — | — | — |
| Sep 2027 | −$0.39 | — | — | $5.8M | — | — | — |
| Jun 2027 | −$0.23 | — | — | $30.3M | — | — | — |
| Mar 2027 | −$0.41 | — | — | $0 | — | — | — |
| Dec 2026 | −$0.39 | — | — | $2.5M | — | — | — |
| Nov 5, 2026 | −$0.39 | — | — | $0 | — | — | — |
| Aug 4, 2026 | −$0.38 | −$0.30 | +21.4% | — | — | — | +3.3% |
| May 14, 2026 | −$0.53 | −$0.31 | +41.5% | — | — | — | −5.1% |
| Mar 19, 2026 | −$0.44 | −$0.73 | −65.9% | — | — | — | +4.0% |
| Nov 5, 2025 | −$0.39 | −$0.61 | −56.4% | — | — | — | −15.3% |
| Aug 14, 2025 | |||||||
| Apr 30, 2025 | |||||||
| Mar 24, 2025 | |||||||
| Oct 30, 2024 | |||||||
| Aug 7, 2024 | |||||||
| May 9, 2024 | |||||||
| Mar 14, 2024 | |||||||
| Nov 14, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 15, 2023 | |||||||
| Mar 14, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 11, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 25, 2022 | |||||||
| Nov 12, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 10, 2021 | |||||||
| Mar 4, 2021 | |||||||
| Nov 10, 2020 | |||||||
| Aug 11, 2020 | |||||||
| May 8, 2020 | |||||||
| Mar 5, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 11, 2019 | |||||||
| Nov 7, 2018 | |||||||
| Aug 7, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 6, 2018 | |||||||
| Nov 7, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 9, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 9, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 11, 2015 |